2022
Maternal-fetal medicine fellows’ perception and comfort with obstetrical ultrasound and prenatal diagnosis
Holliman K, Pluym ID, Grechukhina O, Blumenfeld YJ, Platt LD, Copel JA, Han CS. Maternal-fetal medicine fellows’ perception and comfort with obstetrical ultrasound and prenatal diagnosis. American Journal Of Obstetrics & Gynecology MFM 2022, 4: 100601. PMID: 35217235, DOI: 10.1016/j.ajogmf.2022.100601.Peer-Reviewed Original Research
2021
Special Report of the Society for Maternal-Fetal Medicine Placenta Accreta Spectrum Ultrasound Marker Task Force: Consensus on definition of markers and approach to the ultrasound examination in pregnancies at risk for placenta accreta spectrum
Shainker SA, Coleman B, Timor I, Bhide A, Bromley B, Cahill AG, Gandhi M, Hecht JL, Johnson KM, Levine D, Mastrobattista J, Philips J, Platt L, Shamshirsaz AA, Shipp TD, Silver RM, Simpson LL, Copel JA, Abuhamad A, Medicine S. Special Report of the Society for Maternal-Fetal Medicine Placenta Accreta Spectrum Ultrasound Marker Task Force: Consensus on definition of markers and approach to the ultrasound examination in pregnancies at risk for placenta accreta spectrum. American Journal Of Obstetrics And Gynecology 2021, 224: b2-b14. PMID: 33386103, DOI: 10.1016/j.ajog.2020.09.001.Peer-Reviewed Original ResearchConceptsPlacenta accreta spectrumUltrasound examinationAmerican CollegePrenatal ultrasound evaluationMaternal-fetal medicineAbnormal placental attachmentTask ForcePlacenta percretaMaternal morbidityPlacenta accretaPlacenta incretaAdherent placentaCesarean deliveryUltrasound evaluationDiagnostic medical sonographySonographic markersUltrasound markersPlacental attachmentExpert consensusInvasive placentationDefinition of markersPrenatal detectionAmerican RegistryUltrasoundPregnancy
2008
Stillbirth at Term in Women of Advanced Maternal Age in the United States: When Could the Antenatal Testing Be Initiated?
Bahtiyar M, Funai E, Rosenberg V, Norwitz E, Lipkind H, Buhimschi C, Copel J. Stillbirth at Term in Women of Advanced Maternal Age in the United States: When Could the Antenatal Testing Be Initiated? American Journal Of Perinatology 2008, 25: 301-304. PMID: 18437644, DOI: 10.1055/s-2008-1076605.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultFemaleFetal DeathHumansMaternal AgeRisk FactorsStillbirthTerm BirthUnited StatesConceptsIntrauterine fetal demiseAdvanced maternal ageYears of ageRisk of IUFDAntenatal testingMaternal ageSingleton term deliveriesTerm singleton gestationsProportional hazards modelSingleton gestationsFetal demiseIndependent predictorsMedical complicationsTerm deliveryWomen 25Women 40Risk factorsMaternal raceCongenital anomaliesPrevention databaseHazards modelHaenszel testWomen 15U.S. CentersCochran-Mantel
2001
Transvaginal sonographic evaluation of fetal anatomy at 14 to 16 weeks. Why it is not feasible in the United States.
Copel J. Transvaginal sonographic evaluation of fetal anatomy at 14 to 16 weeks. Why it is not feasible in the United States. Journal Of Ultrasound In Medicine 2001, 20: 710-711. PMID: 11444728, DOI: 10.7863/jum.2001.20.7.710.Commentaries, Editorials and Letters
1998
Autoimmune-Associated Congenital Heart Block: Demographics, Mortality, Morbidity and Recurrence Rates Obtained From a National Neonatal Lupus Registry
Buyon J, Hiebert R, Copel J, Craft J, Friedman D, Katholi M, Lee L, Provost T, Reichlin M, Rider L, Rupel A, Saleeb S, Weston W, Skovron M. Autoimmune-Associated Congenital Heart Block: Demographics, Mortality, Morbidity and Recurrence Rates Obtained From a National Neonatal Lupus Registry. Journal Of The American College Of Cardiology 1998, 31: 1658-1666. PMID: 9626848, DOI: 10.1016/s0735-1097(98)00161-2.Peer-Reviewed Original ResearchConceptsCongenital heart blockNeonatal lupus syndromeSSA/RoWeeks of gestationRecurrence rateLa antibodiesSubsequent pregnancySSA/Ro-SSB/La antibodiesAutoantibody-associated congenital heart blockDevelopment of CHBAnti-SSB/La antibodiesAnti-SSA/RoIsolated congenital heart blockClose echocardiographic monitoringLate second trimesterDays of lifeSSB/LaSufficient medical recordsMajor structural abnormalitiesMaternal autoantibodiesLupus syndromeNeonatal lupusEchocardiographic monitoringLupus RegistryHeart blockCan Risk Factor Screening Predict Hepatitis C Antibody Reactivity?
Magriples U, Bernstein P, Snyder E, Copel J. Can Risk Factor Screening Predict Hepatitis C Antibody Reactivity? American Journal Of Perinatology 1998, 15: 395-398. PMID: 9722062, DOI: 10.1055/s-2007-993964.Peer-Reviewed Original ResearchConceptsHepatitis C virusPercent of womenRisk factorsEnzyme-linked immunoadsorbent assaySecond-generation testingHistory of hepatitisIntravenous drug useNegative predictive valueHCV exposureRF screeningConsecutive patientsProspective studyC virusLower riskAntibody reactivityPredictive valueDrug useImmunoadsorbent assayWomenPatientsScreeningAssaysPercentHepatitisPrevalence
1996
Obstetrics and gynecology ultrasound laboratory accreditation in the USA
Copel J. Obstetrics and gynecology ultrasound laboratory accreditation in the USA. Ultrasound In Obstetrics And Gynecology 1996, 7: 161-162. PMID: 8705404, DOI: 10.1046/j.1469-0705.1996.07030161.x.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
1985
Hermansky-Pudlak syndrome in pregnancy: Two case studies
Reiss R, Copel J, Roberts N, Hobbins J. Hermansky-Pudlak syndrome in pregnancy: Two case studies. American Journal Of Obstetrics And Gynecology 1985, 153: 564-565. PMID: 4061519, DOI: 10.1016/0002-9378(85)90475-2.Peer-Reviewed Case Reports and Technical Notes